ENANTA PHARMACEUTICALS INC's ticker is ENTA and the CUSIP is 29251M106. A total of 154 filers reported holding ENANTA PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2020 | $0 | -100.0% | 0 | -100.0% | 0.00% | -100.0% |
| Q1 2020 | $296,000 | +377.4% | 6 | -71.4% | 0.00% | -97.7% |
| Q4 2019 | $62,000 | +6100.0% | 21 | -12.5% | 0.04% | +4200.0% |
| Q3 2019 | $1,000 | -66.7% | 24 | -20.0% | 0.00% | -50.0% |
| Q2 2019 | $3,000 | -93.9% | 30 | -94.2% | 0.00% | -95.0% |
| Q1 2019 | $49,000 | +1125.0% | 513 | +741.0% | 0.04% | +900.0% |
| Q3 2018 | $4,000 | -20.0% | 61 | +27.1% | 0.00% | -20.0% |
| Q2 2018 | $5,000 | -61.5% | 48 | -63.6% | 0.01% | -61.5% |
| Q1 2018 | $13,000 | – | 132 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Krensavage Asset Management, LLC | 858,811 | $36,156,000 | 10.56% |
| Fairmount Funds Management LLC | 150,433 | $6,333,000 | 2.26% |
| ARMISTICE CAPITAL, LLC | 1,356,000 | $57,088,000 | 1.94% |
| FARALLON CAPITAL MANAGEMENT LLC | 1,775,000 | $74,728,000 | 0.45% |
| Virtus ETF Advisers LLC | 14,321 | $603,000 | 0.25% |
| Granahan Investment Management | 231,071 | $9,728,000 | 0.22% |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 248,320 | $10,454,000 | 0.09% |
| ACADIAN ASSET MANAGEMENT LLC | 467,514 | $19,684,000 | 0.08% |
| VIRTUS ALTERNATIVE INVESTMENT ADVISERS, INC. | 126 | $5,000 | 0.08% |
| AIGEN INVESTMENT MANAGEMENT, LP | 12,854 | $541,000 | 0.07% |